MASSIVE, HUGE, UNMISSABLE SMA EVENT EVER! TreatSMA goes live.

TreatSMA are going live all day on Facebook on the 28th September with a huge event jampacked with speakers covering lots of different aspects of SMA, ranging from physiotherapy to science.

As part of the UK SMA Awareness week is inviting you to watch and participate in our ‘SMA LIVE DAY’ on Saturday 28th September on this event page. This day is a live stream of professionals and community members sharing their experiences, skills and knowledge to the SMA community and wider public which will then spread information and awareness.

This exciting day begins at 8am and will finish at 7pm. We have twenty two people speaking so it is one jam packed day not to be missed. The agenda for the day is as follows:

We have individuals speaking live from the UK, Australia and America. Many will have a question and answer session making their 30 minute slot interactive. A few will be pre recorded but any questions that go unanswered or where you cannot ask directly will be emailed to the speaker after the event.

We hope, as ‘SMA LIVE DAY’ can be watched from your phone or computer anywhere in the world, lots of you will tune in and make it a massive success.

Please share the event and the poster with the full agenda of the day on it and also invite anyone who you feel would be interested or could learn from this event on the event link. https://www.facebook.com/events/1594909840657996/?ti=cl

During the course of the week bios of the speakers will be put up.

Looking forward to the Saturday 28th.

TreatSMA Team

Latest Posts

  • Calling on all the community to ACT NOW to avoid losing treatments!

    Calling on all the community to ACT NOW to avoid losing treatments!

    Currently, there are two approved treatments for SMA: risdiplam and nusinersen. These treatments were initially approved temporarily under Managed Access Agreements while the NHS and NICE gathered data to assess their cost-effectiveness. Now, as these agreements come to an end, both treatments face a crucial review.

    Read more

  • NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam

    SMA UK are proud to join together with Treat SMA and MDUK to bring you this webinar about NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam. 2024 sees the end of the managed access agreements (MAAs) for the two treatments. An expert committee will gather to assess the new clinical and real-world evidence, along…

    Read more

  • Let the battle begin

    Let the battle begin

    This year the Managed Access Agreement for Spinraza and Risdiplam expires. The MAA was put in place five years ago so the pharmaceutical companies could gather more evidence to resubmit to NICE for approval on the NHS with Biogen extending their MAA by a year.

    Read more